Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Working to Uncover the Mode of Action

Posted on March 2nd, 2017 by in Pharma R&D

The New Year has brought some new talent into the Myelo Therapeutics team. In January we welcomed Susann, our new postdoctoral researcher. We’re excited to have someone with her experience, which includes studying molecular biology in Dresden and Heidelberg, Continue reading “Working to Uncover the Mode of Action” »

An Update from Myelo: Expanding Our Team and Evaluating Data

Posted on December 14th, 2016 by in Pharma R&D

The focus of our current non-clinical research at Myelo Therapeutics is to fully elucidate the mode of action for prevention of myelosuppression as well as Myelo001’s antiviral capabilities. But to achieve this goal, it’s important to have highly skilled and motivated personnel within your team. Continue reading “An Update from Myelo: Expanding Our Team and Evaluating Data” »